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Abstract. Reduction in Fc receptor expression as assayed by ‘erythrocyte’ rosetting of 
macrophage cultures from long term treated lepromatous leprosy patients (bactereologically 
negative) was seen in the presence of viable Mycobacterium leprae. Macrophages with and
without intracellular bacilli demonstrated this reduction. On the basis of this observation the 
conditioned medium of Mycobacterium leprae infected macrophage cultures of lepromatous
patients, were tested on macrophages from normal individuals for [3H]-leucine incorporation 
and antigen specific physical interaction with lymphocytes. Both these parameters showed
decreased values as compared to the controls which were not exposed to this conditioned
medium. Lymphocyte transformation to Mycobacterium leprae in leucocyte cultures of
normal individuals was also reduced in the presence of the conditioned medium from
lepromatous patients’ macrophages. The indication that this factor may be a prostaglandin
was suggested by the observation that its synthesis was inhibited by indomethacin. Its
importance in the non-specific depression in cell-mediated immunity seen in lepromatous 
patients is discussed. 
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Introduction
 
An aberrant macrophage response to Mycobacterium leprae in lepromatous leprosy
patients was reported earlier by us. Amongst these were a reduced ability to express Fc 
receptors, a significant reduction in protein synthesis and a negative macrophage-
lymphocyte interaction in the presence of M. leprae. It was observed specifically in the 
first two systems that macrophages containing intracellular Μ. leprae seemed to exhibit
a suppressive effect on macrophages within the same culture not harbouring 
intracellular bacilli (Birdi et al., 1979, 1983). 
The experiments presented here provide indications for the presence of a suppressor
factor released by infected lepromatous macrophages, whose activity is recoverable
from the spent culture medium. Various workers have demonstrated the indomethacin
sensitive nature of prostaglandin synthesis (Goodwin, 1981). On the basis of the
inhibition of the factor by indomethacin it could be suggested that this factor was a
prostaglandin. This factor is distinct from the intracellular factor not affected by
indomethacin reported previously (Salgame et al., 1983).
 
 
Abbreviations used: BI+ve, Bacteriologically positive; BI–ve bacteriologically negative; EA rosetting,
erythrocyte rosetting; SRBC, sensitized sheep erythrocytes; MEM, minimal essential medium; SI, stimulation
index.
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Materials and methods
 
Choice of patients 
 
Leprosy patients were classified according to the Ridley and Jopling classification
(Ridley and Jopling, 1966). Lepromatous patients have been further subdivided as 
bacteriologically positive (BI+ve) i.e. those that harbour acid-fast bacilli in skin 
smears, and bacteriologically negative (BI – ve) i. e. those patients who do not show any
acid-fast bacilli in skin smears.
 
 
Source of M. leprae
 
Biopsies of nodules from lepromatous patients were homogenized and then trypsi-
nized. The M. leprae thus obtained after differential centrifugation was washed with
saline, stored at 4°C and used within a week (Ambrose et al., 1978).
 
 
Macrophages
 
Mononuclear cells were isolated from heparinized peripheral blood by sedimentation
in 6% Dextran. Macrophages were freed from most of the other cells by adherence to
glass. The macrophages thus obtained were maintained for 7 days in minimal essential
medium (MEM) containing 40% human AB serum. The culture medium was changed
every 48 h. 
 
 
Preparation of conditioned medium 
 
Macrophage cultures maintained for 7 days from lepromatous patients were infected in
vitro with 5×106 M. leprae/tube as enumerated by the method of Hanks et al. (1964).
After 24 h the excess M. leprae was washed off and the culture was maintained for an
additional 48 h after which the medium was collected free from cells. The conditioned
medium obtained from 0·3×106 lepromatous macrophages was added to each
normal culture. 
 
 
Fc mediated erythrocyte rosetting (‘EΑ’ rosetting) 
 
M. leprae (5×106) were added to each Leighton tube culture. The cultures were
incubated for 24 h before the excess M. leprae was washed Goff. Macrophages were 
further maintained for 72 h after M. leprae infection before ‘EΑ’ rosetting was carried 
out, using sensitized sheep erythrocytes (SRBC) (Birdi et al., 1983). In brief, SRBC in a 
2% suspension in MEM were sensitized with an equal volume of goat anti-SRBC
antibody. A suspension of 1% sensitized SRBC was overlaid onto the macrophage
monolayer and allowed to rosette for 30 min at 37°C under 5% CO2. Nonrosetted 
SRBC were removed by washing, and the monolayers were fixed in 2·5% glutaral- 
dehyde and stained with Ziehl-Neelsen acid-fast stain to identify M. leprae. The
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percentage of cells with two or more SRBCs attached was determined. A total of 200
cells were counted. The conditioned medium was added 24 h prior to ‘EΑ’ resetting 
where required. The percentage of cells rosetted with three or more SRBCs was 
determined.
 
 
Antigen specific macrophage-lymphocyte physical interaction
 
Mononuclear cells from peripheral blood were isolated on a Ficoll-Triosil gradient.
The cells so obtained consisted of 80% to 90% lymphocytes and 10–20% macrophages. 
The cells were then resuspended in MEM containing 20% human AB serum in a 
concentration of 4×106 cells/ml and distributed into Leighton tubes containing
coverslips. The conditioned medium was added along with 3×106 M. leprae/tube and
the cells were incubated at 37°C for 18 h. The non-rosetted lymphocytes were washed
off and the cells were fixed in 2·5% gluteraldehyde and stained with Ziehl-Neelsen acid-
fast stain. The percentage of macrophages with 2 or more lymphocytes adhering to it
was determined.
 
 
Effect of macrophage conditioned medium on [3H]-leucine incorporation by
macrophages
 
Macrophage monolayer cultures maintained for 7 days were exposed to the con-
ditioned medium from various sources. Control cultures were maintained to which no 
conditioned medium was added in vitro. The cells were then labelled for 3 h with 1- 
µCi/ml [3H]-leucine (sp. act. 7·7 Ci/mmol) and further processed for scintillation 
counting. Radioactivity was measured in the trichloroacetic acid insoluble portion. 
Incorporation of the precursor added in control cultures was taken as the index of 
baseline incorporation in the macrophages. Per cent difference between experimental
and control cultures was calculated.
 
 
Lymphocyte transformation
 
Mononuclear cells were separated over a Ficoll Triosil gradient. A cell count was taken 
by diluting with Turks fluid and the suspension was also checked for viability using
0·3% trypan blue. The cell suspension was adjusted to 1×106 cells/ml in culture 
medium (MEM+20% AB serum). Aliquots of 0·1 ml were distributed in each well of a 
microtitre plate. The M. leprae (3×106/ml) was distributed in 0·1 ml amounts into each 
well. The cultures were harvested on the sixth day. Each culture combination was set up
in triplicate. Eighteen h prior to harvesting the cultures, 1 µCi/ml [3H]-thymidine (sp.
act. 9·8 Ci/mmol) was added to each well. Cells were processed for scintillation counting 
to determine the incorporation of [3H]-thymidine and the stimulation index (SI) was
defined as the ratio of radioactivity incorporated in the experimental over that of
control. 
 
 
Treatment with indomethacin
 
Indomethacin (1 μg/ml) was added to the cultures for a period of 24 h prior to the assay.
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Treatment with cycloheximide 
 
The effect of cycloheximide (2µg/ml Sigma no. C6255) was tested using ‘EΑ’ resetting 
assay on macrophages of lepromatous (BI–ve) patients. Two protocols were used. In 
one set of experiments, M. leprae and cycloheximide were added simultaneously and 
incubated overnight. These cultures were maintained in medium containing cyclohe- 
ximide after the excess antigen was washed off for 48 h after which ‘EΑ’ rosetting was 
done. 
In a second set of experiments 24 h after M. leprae infection of the macrophage
cultures, cycloheximide was added 48 h before ‘EΑ’ rosetting was carried out.
 
 
Results 
 
Effect on ‘EΑ’-rosetting
 
Macrophages from M. leprae infected cultures of lepromatous patients were divided
into two populations—macrophages containing intracellular bacilli and those without.
Since reduced rosetting was seen in both populations, it was probable that M. leprae 
interacted with the macrophages producing a factor that reduced the Fc activity of the
macrophage in which it resided. Simultaneously these macrophages also secreted the
inhibitory factor into the surrounding medium which reduced the rosetting capacity of 
other macrophages (figure 1). 
This was confirmed by assessing the inhibitory function of the secreted factor on all 
the three macrophage parameters.
 
Effect on [3H]-leucine incorporation into normal macrophages by the conditioned medium
obtained from M. leprae infected macrophage cultures
 
The conditioned medium obtained from M. leprae infected macrophage cultures from
 
Figure 1. ‘EΑ' rosetting of macrophages from 
lepromatous (BI—ve) patients in the presence of
viable M. leprae. Each line represents 3 sets of
values from a single patient. The variation in each
vertical column represents the range of values. 
C, aControl, uninfected macrophage culture. I, M.
leprae infected macrophage culture. Μφ,
bMacrophages with no intracellular Μ. leprae.
Μφ ML, cMacrophage with intracellular Μ. leprae,
a: c, Ρ < 0·005; b: c, not significant.
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normal individuals and tuberculoid patients did not decrease the [3H]-leucine
incorporation in normal macrophages (figure 2). However in the presence of the
conditioned medium from M. leprae infected macrophage cultures of lepromatous
patients, the [3H] -leucine incorporation of normal macrophages was reduced. If the
macrophages from lepromatous (BI–ve) patients were infected with heat-killed M.
leprae, no reduction in [3H]-leucine incorporation was noted.
 
 
Effect on macrophage-lymphocyte normal interaction by the conditioned medium obtained
from M. leprae infected macrophage cultures of lepromatous patients
 
Normal interaction in the presence of antigen (M. leprae, PPD) was reduced if the
lepromatous conditioned medium was introduced into the system but the levels were
not lower than the baseline value of 10%. Therefore it appears that the factor in the
conditioned medium is not specific in function (figure 3).
 
 
Effect on lymphocyte proliferation
 
M. leprae induced lymphocyte proliferation of normal individuals was inhibited in the
presence of the conditioned medium prepared from lepromatous (BI—ve) macrophage
infected in vitro with M. leprae (table 1). However the supernatant collected from
lepromatous (BI—ve) macrophages alone had no suppressor activity.
 
 
Effect of cycloheximide on the production of the inhibitory factor/s 
 
The requirement for protein synthesis by the macrophages from lepromatous (BI—ve) 
patients was assessed using a protein synthesis inhibitor-cycloheximide. It is evident
from the data presented in figure 4A that the levels of ‘EΑ’ rosetting are restored in both
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Figure 2. Effect of M. leprae infected macrop-
hage supernatant on [3H]-leucine incorporation
by normal macrophages. SN, Spent medium from
macrophage cultures of normal subjects infected
with viable M. leprae. S T, Spent medium from
macrophage cultures of tuberculoid patients in-
fected with M. leprae. S L, Spent medium from
macrophage cultures of lepromatous patients in-
fected with M. leprae. S LA, Spent medium macrop-
hage cultures of lepromatous patients infected
with autoclaved M. leprae. The results are ex-
pressed as mean ± SE (n = 5). 
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Table 1. The effect of the culture supernatant on M. leprae induced lymphocyte prolifer-
ation in normal individuals. 
 
 
aSupernatant was collected from bacillary negative lepromatous macrophages. Supernatant was assayed
for suppressive activity in a normal lymphocyte proliferation assay to M. leprae antigen. 
Control, Supernatant from macrophage cultures not exposed to M. leprae. 
Μ. leprae, Supernatant from macrophage cultures exposed to M. leprae. 
Indometacin, Supernatant from macrophage cultures exposed to indomethacin only. 
M. leprae+indomethacin, Supernatant from macrophage cultures exposed to M. leprae + indomethacin.
bThe difference in response between normal peripheral blood mononuclear cells stimulated with M. leprae
and the unstimulated background count.
 
macrophage populations i.e. those containing intracellular Μ. leprae and those
without, if the drug is added along with M. leprae. 
However if bacilli were added 48 h prior to the addition of cyclohemixide, only the
macrophages with no intracellular bacilli showed improved levels of rosetting (figure
4B). These kinetic results therefore implicate two factors that mediate suppression. The
first is a stable early interaction product contained interacellularly. The second is
continously produced and secreted by the macrophages with intracellular Μ. Leprae
and mediates amplification.
 
 
Effect of indomethacin on the factor secreted by the macrophages
 
‘EA' rosetting: The possibility that this factor was a prostaglandin was investigated by
checking if its synthesis was blocked by indomethacin.
Figure 3. Efect of lepromatous macrophage
supernatant on normal macrophage-lyphocyte
interaction to M. leprae or purified tuberculin
(PPD). Each line represents values from a single
patient Sup, Conditioned medium from macrop-
hage cultures of lepromatous patients infected
with M. leprae PPD. 
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Figure 4. Effect of cycloheximide on the production of the inhibitory factor. M. lep
+ cycloheximide: Both added simultaneously M. lep — cycloheximide: M. leprae added 24 h 
prior C, Uninfected macrophage cultures. I, M. leprae infected macrophage cultures. Mφ,
Macrophages without intracellular Μ. leprae. Mφ ML, Macrophages with intracellular Μ. 
leprae. (Ο),Untreatedcultures; (?), culture treated with cycloheximide. Each symbol in all the
3 panels denotes a single patient. 1:4, Not significant; 5:6, not significant; 8:9, Ρ < 0·005; 4:5,
not significant; 7:8, Ρ < 0·005.
 
‘ΈΑ’ rosetting of macrophages from lepromatous (BI—ve) patients infected with M.
leprae in vitro and treated with indomethacin was determined. With this reagent present 
in the culture, macrophages devoid of intracellular acid fast bacilli did not show any 
reduction in their capacity to form rosettes with sensitized SRBC. However, cells 
harbouring M. leprae continued to show the same low level of rosetting values similar
to those seen in indomethacin free cultures (figure 5).
Figure 5. ‘EΑ’ rosetting of macrophages from
lepromatous (BI—ve) patients. A. Control cul-
tures. B. Indomethacin treated cultures. Each 
symbol represents one lepromatous patient, w,
Macrophage with intracellular Μ. leprae, w/o, 
Macrophages without intracellular Μ. leprae, mφ
cult, Macrophage cultures from lepromatous (BI 
—ve) patients, mφ cult. + M. lep, Macrophage
cultures from lepromatous (BI—ve) patients in-
fected with M. leprae. 1:2, Ρ < 0·01; 2:3, not
significant; 5:6, Ρ < 0·001; 2:5, not significant;
3:6, P<0·001. 
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Lymphocyte proliferation assay: The supernatants of indomethacin treated lepromat-
ous cultures failed to show any inhibitory action on a normal M. leprae induced
lymphocyte proliferation assay (table 1).
 
 
Discussion
 
It is clear from the data presented that macrophages of lepromatous leprosy patients on 
incubation with M. leprae release a factor that alters some basic functions of normal
macrophages. 
The factor released in macrophage culture medium is specific for an interaction
between viable M. leprae only and macrophages from a lepromatous patient. The
depression was not seen with the conditioned medium from tuberculoid or normal 
individuals macrophages infected with 5×106 M. leprae/culture or heat killed M.
leprae and in earlier studies on Fc receptor expression (Birdi et al., 1983). 
Studies carried out in our laboratory have also demonstrated the presence of a 
specific intracellular suppressor factor in the lysed preparations of lepromatous 
macrophages infected with viable M. leprae (lysate) which was capable of altering
normal macrophage function. The extracellular factor reported in this paper differs
from the product retained within the infected macrophage (Salgame et al., 1980).
Studies by Preston (1979) demonstrated 2 factors in M. lepraemurium infected mice,
one able to activate and the other able to suppress. In resistant mice the activating factor
played a major role while in susceptible mice the suppressor factor was dominant. It is 
possible that the increase in [3H]-leucine seen with the conditioned medium from
tuberculoid patients is due to a similar factor.
Addition of indomethacin in our system did not increase ‘EΑ’ rosette values of cells
containing bacilli, though it did augment ‘EΑ’ rosette formation in uninfected cells. In
the former therefore there are two possibilities. The first is that the decrease in rosette
forming cells in bacillary positive cells is not due to prostaglandin or that an
intracellular pool of prostaglandin exists within the macrophage which reduces the
rosetting capacity of the cell. If the latter were true, then the continuous release of
prostaglandin formed prior to indomethacin addition would not be inhibited by an
antagonist of prostaglandin synthesis and a depression would be apparent in the
rosetting activity of the uninfected cells. This is not so (figure 5). Therefore this line of
argument supports the first possibility that non-prostaglandin materials may be
responsible only for reduced rosetting in the cells containing bacilli. 
The kinetic results with cycloheximide show that the intracellular indomethacin
resistant factor may be produced in the early stages of interaction since a lapse of 48 h
between antigen addition and cycloheximide addition does not result in an increase of 
rosetting activity of cells harbouring acid fast bacilli. However cells not harbouring 
intracellular bacilli do not show any depression suggesting that the second factor is
indomethacin sensitive and is continuously produced and secreted.
This subserves the notion that the two factors viz. lysate and prostaglandin act as 
independent entities and that suppression brought on by one is independent of the
action of the other. Turcotte and Lemieux (1982) are supportive in their observations
that in BCG infected mice the suppression is mediated by two different mechanisms.
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The presence of a suppressor factor has also been reported by Satish et al. (1983).
Recent results obtained by Bahr et al. (1981) suggested that a normal prostaglandin
dependent indomethacin sensitive regulatory mechanism was absent from the peri-
pheral blood nonnuclear cells of lepromatous patients. Our data show that the 
production of a specific suppressor factor is not affected by indomethacin. It is
therefore probable that the lymphocyte transformation test utilized by them detected in
lepromatous (BI+ve) patients the indomethacin resistant factor as identified by us. It is
conceivable that in these patients immunodepression would be modulated mainly
through the specific suppressor factors that are not prostaglandins (lysate).
It is not clear whether the difference between the normal and lepromatous 
supernatant is qualitative or quantitative. It is probable that the amount of regulatory
factor released by lepromatous macrophages far exceeds that produced by normal 
macrophages or that it makes an appearance at earlier stages of infection. Either way it 
culminates in a premature suppression of the immune response by macrophages 
uneffected by M. leprae, adding to the several abnormal sequence of events occurring 
inside the cells infected with M. leprae. 
The possibility exists that the non-specific anergy seen in extremely bacilliferous 
lepromatous patients is due to the non-specific depression of the immune response by 
prostaglandins released by infected macrophages. On treatment, these lepromatous 
patients demonstrate a reduction in their bacillary load and regain their cell-mediated 
immunity to unrelated antigens but continue to show a specific anergy to M. leprae.
The importance of the regulation of the immuno response by prostaglandins has 
been emphasized by the finding that the altered immune response in Hodgkin’s disease
may be caused by the increased production of prostaglandins (Goodwin et al. al., 1977). 
Studies carried out by us have demonstrated an altered macrophage topography in
lepromatous patients. These observations conform with those of Oropeza-Rendon et al. 
(1980) who have shown that prostaglandins alter the configuration of the macrophage 
membrane. Concanavalin A activated cells have shown that monocyte suppressive
activity is predominantly mediated through the release of prostaglandin E2 which 
induces suppressor T cells. The induction of T-suppressor cells in lepromatous leprosy 
could be the result of a similar mechanism. 
Studies carried out by Shand et al. (1981) demonstrate that T lymphocytes do not 
require to undergo proliferation or differentiation to function as suppressor cells since 
colchicine could prevent suppressor activity. This result indicates the probability that it 
is a membrene-linked phenomenon. Thus prostaglandin E2 maybe acting via this 
mechanism in the induction of suppressor Τ cells. 
While prostaglandins appear to suppress cell mediated immunity directly, in
humoral immunity they are necessary but not sufficiency for inhibition since direct 
addition of prostaglandin to plaque forming cells in vitro is generally not suppressive 
but prostaglandin synthetase inhibitors enhance humoral responses (Robertson, 1981). 
It is accepted that in lepromatous leprosy the humoral response is not reduced and
there is suppression only of CMI responses.
It is likely therefore that M. leprae not only evades the host immune defence system 
but also activates a suppressor mechanism via the host’s own surveillance network.
Prostaglandin synthesis may be one such mechanism that is affected.
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